Related Experiment Video
Updated: Nov 16, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction
Michele Russo1, Rocco A Montone2, Domenico D'Amario2
1Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, L.go F. Vito, 1, 00168, Rome, Italy.
Aims:
Coronary microvascular obstruction (MVO) occurs frequently in patients with ST-elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI). However, mechanisms are multiple and not yet fully understood. Perilipin 2 (PLIN2) is involved in lipid metabolism of macrophages resident in atherosclerotic plaques, along with a role in enhancing plaque inflammation. We studied the association between PLIN2 and MVO in STEMI patients undergoing primary PCI, and we assessed the role of PLIN2 to predict major adverse cardiovascular events (MACEs).
Methods And Results:
STEMI patients undergoing primary PCI were enrolled. PLIN2 was evaluated in peripheral blood monocytes; MVO was assessed using coronary angiogram. MACEs, as a composite of cardiac death, non-fatal myocardial infarction, re-admission for heart failure, and target vessel revascularization were investigated at follow-up. Among 100 STEMI patients, 33 (33.0%) had MVO. Patients with MVO had higher levels of PLIN2 (1.03 ± 0.28 vs. 0.90 ± 0.16, P = 0.019). Age [odds ratio (OR) (95% confidence interval, CI), 1.045 (1.005-1.087), P = 0.026] and PLIN2 [OR (95% CI), 16.606 (2.027-136.030), P = 0.009] were associated with MVO at univariate analysis, although only PLIN2 [OR (95% CI), 12.325 (1.446-105.039), P = 0.022] was associated with MVO at multivariate analysis. After a mean follow-up of 182.2 ± 126.6 days, 13 MACEs occurred. MVO [hazard ratio (HR) (95% CI), 6.791 (2.053-22.462), P = 0.002], hypercholesterolaemia [HR (95% CI), 3.563 (1.094-11.599), P = 0.035], and PLIN2 [HR (95% CI), 82.991 (9.857-698.746), P < 0.001] were predictors of MACEs at univariate analysis, although only PLIN2 [HR (95% CI), 26.904 (2.461-294.100), P = 0.007] predicted MACEs at multivariate analysis.
Conclusions:
In STEMI patients undergoing primary PCI, PLIN2 was independently associated with MVO and was an independent predictor of MACEs at follow-up, suggesting to further explore PLIN2 as a target for future cardioprotection therapies.
Insights
Perilipin 2 (PLIN2) levels in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI) are linked to microvascular obstruction (MVO) and predict major adverse cardiovascular events (MACEs). Further research into PLIN2 as a cardioprotective target is suggested.
Area of Science:
- Cardiology
- Biochemistry
- Vascular Biology
Background:
- Coronary microvascular obstruction (MVO) is a frequent complication after percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients.
- The precise mechanisms underlying MVO remain incompletely understood.
- Perilipin 2 (PLIN2) plays a role in macrophage lipid metabolism and plaque inflammation, suggesting a potential involvement in MVO pathogenesis.
Purpose of the Study:
- To investigate the association between PLIN2 levels and MVO in STEMI patients undergoing primary PCI.
- To evaluate the predictive role of PLIN2 for major adverse cardiovascular events (MACEs) in these patients.
Main Methods:
- A cohort of STEMI patients undergoing primary PCI was studied.
- PLIN2 levels were measured in peripheral blood monocytes.
- MVO was assessed via coronary angiography.
- MACEs (cardiac death, non-fatal MI, heart failure readmission, target vessel revascularization) were tracked during follow-up.
Main Results:
- 33% of the 100 STEMI patients experienced MVO.
- Patients with MVO exhibited significantly higher PLIN2 levels compared to those without MVO (P=0.019).
- Multivariate analysis confirmed PLIN2 as an independent predictor of MVO (OR=12.325, P=0.022) and MACEs (HR=26.904, P=0.007).
Conclusions:
- PLIN2 is independently associated with MVO in STEMI patients post-PCI.
- PLIN2 serves as an independent predictor of MACEs following STEMI.
- These findings highlight PLIN2 as a potential therapeutic target for cardioprotection in STEMI.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction

